Sulprostone reduces the need for manual removal of the placenta in patients with retained placenta: a randomized controlled trial
- PMID: 17346503
- DOI: 10.1016/j.ajog.2006.09.045
Sulprostone reduces the need for manual removal of the placenta in patients with retained placenta: a randomized controlled trial
Comment on
-
Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial.Am J Obstet Gynecol. 2006 Feb;194(2):446-50. doi: 10.1016/j.ajog.2005.08.029. Am J Obstet Gynecol. 2006. PMID: 16458644 Clinical Trial.
Similar articles
-
Sulprostone reduces the need for the manual removal of the placenta in patients with retained placenta: a randomized controlled trial.Am J Obstet Gynecol. 2006 Feb;194(2):446-50. doi: 10.1016/j.ajog.2005.08.029. Am J Obstet Gynecol. 2006. PMID: 16458644 Clinical Trial.
-
Intravenous sulprostone infusion in the treatment of retained placenta.Acta Obstet Gynecol Scand. 2013 Apr;92(4):426-32. doi: 10.1111/j.1600-0412.2012.01506.x. Epub 2012 Aug 21. Acta Obstet Gynecol Scand. 2013. PMID: 22862433
-
Rectal misoprostol in management of retained placenta: a contradictory result.J Med Assoc Thai. 2011 May;94(5):535-9. J Med Assoc Thai. 2011. PMID: 21675440
-
Medical management of early pregnancy failure: how to treat and what to expect.Semin Reprod Med. 2008 Sep;26(5):401-10. doi: 10.1055/s-0028-1087106. Epub 2008 Sep 29. Semin Reprod Med. 2008. PMID: 18825608 Review.
-
What is the optimal pharmacological management of retained placenta?BMJ. 2014 Jul 28;349:g4778. doi: 10.1136/bmj.g4778. BMJ. 2014. PMID: 25069774 Review. No abstract available.
Cited by
-
Uterotonics for management of retained placenta.Cochrane Database Syst Rev. 2024 Oct 28;10(10):CD016147. doi: 10.1002/14651858.CD016147. Cochrane Database Syst Rev. 2024. PMID: 39465684
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources